United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 28, 2026 · Filed Jul 28, 2026

On Jul 28, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$526.73 for US$5M under a trading plan, leaving 324,443 shares. Filed Jul 28, 2026 (Form 4).

Sold
9,500 shares
Price
US$526.73 average (US$523.15 to US$532.49)
Value
US$5M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 28, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 28, 2026Common StockSale1,367US$523.15332,576Indirect
Jul 28, 2026Common StockSale1,074US$524.04331,502Indirect
Jul 28, 2026Common StockSale876US$525.02330,626Indirect
Jul 28, 2026Common StockSale1,473US$526.34329,153Indirect
Jul 28, 2026Common StockSale1,369US$527.16327,784Indirect
Jul 28, 2026Common StockSale1,149US$528.20326,635Indirect
Jul 28, 2026Common StockSale625US$529.41326,010Indirect
Jul 28, 2026Common StockSale1,124US$530.29324,886Indirect
Jul 28, 2026Common StockSale403US$530.97324,483Indirect
Jul 28, 2026Common StockSale40US$532.49324,443Indirect

Source

View original at SEC

Related